Related Experiment Video
Updated: Jul 12, 2026
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Can we prevent diabetic ketoacidosis in children?
1Joslin Diabetes Center, Section on Genetics and Epidemiology, Pediatric, Adolescent, and Young Adult Section, Harvard Medical School, MA 02215, USA.
Insights
Diabetic ketoacidosis (DKA) is a serious diabetes complication. Early education on sick-day management and new blood ketone tests can help prevent hospitalizations for DKA, especially in youth with type 1 diabetes.
Area of Science:
- Endocrinology
- Metabolic Disorders
- Diabetes Management
Background:
- Diabetic ketoacidosis (DKA) is a severe, life-threatening diabetes complication affecting over 100,000 people annually in the US.
- DKA is the primary cause of hospitalization, morbidity, and mortality in youth with type 1 diabetes (T1D).
- Despite advances in diabetes care, DKA remains a significant challenge.
Purpose of the Study:
- To emphasize the importance of outpatient education for sick-day management in preventing DKA.
- To highlight the role of early identification and treatment of impending DKA.
- To explore the potential of new blood ketone detection technologies for early DKA intervention.
Main Methods:
- Review of current DKA management and prevention strategies.
- Emphasis on patient education regarding sick-day rules, self-monitoring of blood glucose and ketones, and insulin/fluid administration.
- Discussion of emerging technologies for blood ketone (3beta-hydroxybutyrate) monitoring.
Main Results:
- Effective sick-day management education can improve self-care and reduce DKA incidence.
- Early detection and treatment of DKA symptoms are crucial for better outcomes.
- New blood ketone tests show promise for earlier DKA identification compared to urine tests.
Conclusions:
- Enhanced outpatient education on sick-day management is vital for preventing DKA in established diabetes.
- Increased awareness of DKA symptoms and surveillance in high-risk groups can aid prevention.
- Technological advancements in blood ketone monitoring offer a promising avenue for early DKA detection and reduced hospitalizations.
Abstract:
Diabetic ketoacidosis (DKA) is an acute potentially life-threatening complication of diabetes affecting more than 100,000 persons annually in the United States. Although major advances have improved diabetes care, DKA remains the leading cause of hospitalization, morbidity, and death in youth with type 1 diabetes (T1D). As the majority of patients presenting with DKA have established diabetes, it is important to address outpatient educational approaches directed at sick-day management and early identification and treatment of impending DKA. Teaching and reinforcement of sick-day rules involves improved self-care with consistent self-monitoring of blood glucose and ketones, and timely administration of supplemental insulin and fluids. DKA as an initial manifestation of T1D may be less amendable to prevention except with an increased awareness by the lay and medical communities of the symptoms of diabetes and surveillance in high-risk populations potentially identified by family history or genetic susceptibility. New technologies that can detect the blood ketone 3beta-hydroxybutyrate (3beta-OHB) instead of traditional urine ketones appears to provide opportunity for early identification and treatment of impending DKA leading to reduced need for hospitalization and potential cost-savings.
Related Concept Videos
01:25Diabetic Ketoacidosis l: Introduction
01:22Diabetic Ketoacidosis ll: Pathophysiology
01:22Diabetes Mellitus: Type 2 and Gestational
01:22Complications of Diabetes Mellitus
01:28Diabetic Nephropathy
01:20Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...